NGS臨床試驗與MTB會議結果分析：對癌症治療有幫助嗎？NGS Clinical Trials and MTB Meeting Results: Benefit Cancer Treatment?

這段影片將探討NGS（次世代基因定序）技術在臨床試驗中的應用，以及MTB（分子腫瘤委員會）會議對癌症治療的影響。許多研究表明，透過NGS技術進行的基因分析，結合MTB會議的多學科專家討論，能幫助制定個性化的治療方案。然而，這些技術是否真能提升治療效果？本影片將分析臨床試驗結果，解釋NGS和MTB會議的實際幫助，並討論它們對癌症患者的預後有何影響。

This video will explore the application of Next-Generation Sequencing (NGS) in clinical trials and the impact of Molecular Tumor Boards (MTB) on cancer treatment. Numerous studies suggest that genetic analysis through NGS, combined with multidisciplinary expert discussions in MTB meetings, can help tailor personalized treatment plans. But do these approaches truly improve treatment outcomes? In this video, we will analyze clinical trial results to assess the practical benefits of NGS and MTB in cancer therapy, and discuss their impact on patient prognosis.